From December 2014-December 2016, this blog entry records an informal log of online news articles about Theranos. I do not review it for the dead links that likely accumulate over time.
The original lead paragraphs of this blog, written back in December 2014, were archived here.
For an update on the March 2018 SEC action against Theranos, here.
I'll add one note from June 2018 - an article that, "Pathologists predicted the Theranos debacle, but their voices were missing from most news coverage"!! Here. (Archived here).
March 21, 2006
"Theranos Secures $10M in VC."
Fierce Healthcare. Here.
June 22, 2006
"The Lifesaver" 30 under 30 2006, Elizabeth Holmes.
Subtitled, "Elizabeth Holmes left college to bring her invention to market. She just might end up saving hundreds of thousands of lives."
Inc. Magazine. by Jasmine D. Adkins. Here.
December 7, 2006
"Theranos Raises $28.5M for Device Tracking Effects of Drugs on Patients."
Venture Beat. Here.
March 4, 2009.
"Developing the Future of Home Healthcare." [PODCAST]
Stanford Entrepreneurship Corner. 57 minutes. Here.
For additional detail, see here.
July 8, 2010
"Theranos Raises $45M for Personalized Medicine."
Xconomy. By Luke Timmerman. Here.
Links to Inc magazine (2006, above) and and to SEC (2010, below). Includes a now-dead link to a profile in "Red Herring" magazine, also 2006. Another reference to the lost article, here.
July 8, 2010
"Theranos raises $45M to help patients track drug reactions."
Venture Beat. By Julie Klein. Here.
July 8, 2010
Theranos $45M SEC Filing.
Addresses, board members, and filing dollar amount only.
Link from Xconomy, above. Here.
August 30, 2013
"Theranos: The Biggest Biotech You've Never Heard of."
San Francisco Business Times. By Ron Leuty. Here.
September 8, 2013
"Elizabeth Holmes: The Breakthrough of Instant Diagnosis."
The pivotal Wall Street Journal article, by Joseph Rago. Here
A Stanford dropout is bidding to make tests more accurate, less painful - and at a fraction of the current price.
September 9, 2013
"Secretive Theranos emerging partly from shadows."
SF BizJournal, SF/Biotech, by Ron Leuty, subtitled, "The biggest biotech you've never heard of." Here. Some discussion of funding rounds and lawsuits.
Mentions 2007 lawsuit against 3 employees starting a new company. Other lawsuit links discuss a patent dispute January 7, 2013 (here, 200 pp. complaint here), March 13, 2013 (here), August 5, 2013 (here), September 24, 2013 (here, denies summary judgement for defendant, here), March 14, 2014 (here), March 17, 2014 (here). Resolved by settlement in mid-trial; competing patent 7,824,612 declared invalid (here, here.) Several readily available Theranos patents include 8697377 (priority date, october 2, 2017, filing June 12, 2013, publication April 15, 2014), 8741230 (Priority date March 24, 2006, filing October 30, 2006, publication June 3, 2014), and 8822167 (priority date October 2, 2007, filing May 8, 2013, publication September 2, 2014).
October 9, 2013
"Just a Drop Will Do."
Pediatric News. By William Wilkoff. Here.
Mentions 2007 lawsuit against 3 employees starting a new company. Other lawsuit links discuss a patent dispute January 7, 2013 (here, 200 pp. complaint here), March 13, 2013 (here), August 5, 2013 (here), September 24, 2013 (here, denies summary judgement for defendant, here), March 14, 2014 (here), March 17, 2014 (here). Resolved by settlement in mid-trial; competing patent 7,824,612 declared invalid (here, here.) Several readily available Theranos patents include 8697377 (priority date, october 2, 2017, filing June 12, 2013, publication April 15, 2014), 8741230 (Priority date March 24, 2006, filing October 30, 2006, publication June 3, 2014), and 8822167 (priority date October 2, 2007, filing May 8, 2013, publication September 2, 2014).
October 9, 2013
"Just a Drop Will Do."
Pediatric News. By William Wilkoff. Here.
November 6, 2013
"What Heath Care Needs is a Real Time Snapshot of You."
WIRED, By Daniela Hernandez. Here.
November 13, 2013.
"One Small Ow-eee."
PediaBlog. By Ned Ketyer MD. Here.
November 18, 2013
"Creative disruption? She's 29 and Set to Reboot Lab Medicine."
November 13, 2013.
"One Small Ow-eee."
PediaBlog. By Ned Ketyer MD. Here.
November 18, 2013
"Creative disruption? She's 29 and Set to Reboot Lab Medicine."
February 18, 2014
"This Woman Invented a Way to Run 30 Lab Tests on Only One Drop of Blood."
WIRED again, by Caitlin Roper. Here. WIRED revisits Holmes, with an interview.
February 28, 2014
"Stanford Dropout Revolutionizes Blood Tests"
Take Part, by Liana Aghajanian. Here.
June, 2014
Hematology Reports (Open Access Journal). Full article PDF: Here.
Chan SM, Chadwick J, Young DL, Holmes E, & Gotlib J (2014). Intensive serial biomarker profiling for the prediction of neutropenic fever with hematologic malignancies undergoing therapy: a pilot study. Hematology Reports 6(2).
Pubmed Central, here.
June 12, 2014
"This CEO is Out for Blood."
June 17, 2014
"Elizabeth Holmes, Who Wants To Shake Up The Blood Testing Industry, Is A Billionaire At 30."
Forbes [blog], by - Zina Moukheiber. Here.
Comments online.
Comments online.
July 2, 2014
"Bloody Amazing."
Forbes [blog 7/2, and Issue, 7/21], by Mathew Herper. Here.
June 3, 2014
US Patent: "Systems and Methods of Sample Processing and Fluid Control in a Fluidic System."
PDF, Patent 8,742,230 B2, 80 pp.. Here.
"This invention is in the field of medical devices...portable medical devices that allow real-tie detection of analytes from a biological fluid...for providing point-of-care testing for a variety of medical applications."
June 20, 2014
"Theranos: Small Sample, Big Opportunity."
Decibio [Consultancy blog]. By Eric Lakin. Here.
June 3, 2014
US Patent: "Systems and Methods of Sample Processing and Fluid Control in a Fluidic System."
PDF, Patent 8,742,230 B2, 80 pp.. Here.
"This invention is in the field of medical devices...portable medical devices that allow real-tie detection of analytes from a biological fluid...for providing point-of-care testing for a variety of medical applications."
June 20, 2014
"Theranos: Small Sample, Big Opportunity."
Decibio [Consultancy blog]. By Eric Lakin. Here.
July 8, 2014
"Nanotainer Revolutionizes Blood Testing." VIDEO
USA TODAY. Here.
July 15, 2014
"Meet Elizabeth Holmes, Silicon Valley's Latest Phenomenon"
San Jose Mercury News, by Michelle Quinn. Here.
July 15, 2014
"Theranos bringing 500 new jobs to Scottsdale's SkySong."
Phoenix Business Journal. By Angela Gonzales. Here. [SkySong is an ASU-affiliated tech park].
July 21, 2014
"Meet Elizabeth Holmes, the Youngest Female Self-made Billionaire Changing the World with Medical Technology."
Women's ILAB, by Katherine Melescuic. Here.
August 11, 2014
"Ignoring Lab Industry, Theranos Goes Its Way."
"My Visit to Walgreens for Theranos Lab Tests."
DARK REPORT (Paper by subscription only). Table of contents here.
September 8, 2014
For further details, see here.
September 8, 2014
"Elizabeth Holmes takes Theranos' blood test to tech movers, shakers."
Biotech SF / Bizjournals - by Ron Leuty. Discussion of TechCrunch presentation. Here.
September 29, 2014
"This Woman's Revolutionary Idea Made Her A Billionaire — And Could Change Medicine."
Business Insider. By Kevin Loria. Here. See also June 4, 2015.
September 29, 2014
"This Woman's Revolutionary Idea Made Her A Billionaire — And Could Change Medicine."
Business Insider. By Kevin Loria. Here. See also June 4, 2015.
September 30, 2014
"Queen Elizabeth: Mystique of Theranos founder grows with Forbes' richest ranking."
Biotech SF / Bizjournals - by Ron Leuty. Here.
October, 2014
"Health Plans Deploy New Systems to Control Use of Lab Tests."
Managed Care. By Joseph Burns. Here.
Does not directly cite Theranos. Cites contrasting viewpoints on the value of direct easy inexpensive test access:
[Kim] Riddell MD [of Group Health, Seattle] rejects arguments ... that routine testing has low cost and helps to identify disease early. “It’s not so much the cost of the test itself; the downstream effects on the health care system are expensive as a consequence of testing. Testing leads to more testing, especially if there are false positives. It creates needless costs because any abnormal value needs more testing and perhaps a referral to a specialist. Maybe the patient has to return to have more blood drawn. It creates unnecessary noise without improving the quality of care,” she says.
October 1, 2014
"How One Entrepreneur is Transforming Blood Testing."
Slate - by Kevin Loria. Here. [Reprint from Business Insider, 9/29, above.]
October 16, 2014
"She's America's Youngest Female Billionaire - And a Dropout."
by Rachel Crane.
CNN/Money. Here. [Text & Video.]
October 27, 2014
"Theranos Due Diligence: Company Profile, SWOT Analysis, Market Opportunity."
Decibio. Consulting group profile of Theranos and its valuation and market position (73 pages; $850). Here. Table of Contents, here. Additional description here.
October 16, 2014
"She's America's Youngest Female Billionaire - And a Dropout."
by Rachel Crane.
CNN/Money. Here. [Text & Video.]
October 27, 2014
"Theranos Due Diligence: Company Profile, SWOT Analysis, Market Opportunity."
Decibio. Consulting group profile of Theranos and its valuation and market position (73 pages; $850). Here. Table of Contents, here. Additional description here.
November 7, 2014
For further details, see here.
November 7, 2014
"Major Upside for Walgreens Stock"
InvestorPlace. By John Divine. Here.
"The single biggest catalyst for WAG stock in the future may be the company’s decision to partner with the privately held health-tech firm Theranos."
November 7, 2014
"Major Upside for Walgreens Stock"
InvestorPlace. By John Divine. Here.
"The single biggest catalyst for WAG stock in the future may be the company’s decision to partner with the privately held health-tech firm Theranos."
December 8, 2014
Fortune/Youtube - Theranos Billionaire Founder Talks Growth. VIDEO.
Video interview with Pattie Sellers. Here.
For further details, see here.
December 8, 2014
"Here's How the World's Youngest Self-Made Female Billionaire Shows People She's In Charge."
Business Insider. By Richard Feloni. Here.
December 8, 2014
"The New Yorker on the Promise, the Secrecy, and the Challenges of Super-Startup Theranos."
MedCityNews. by Meghana Keshavan. Here.
December 12, 2014
"Behind the Curtain at Theranos."
NBC News. (Video). Interview with Ken Auletta. Here.
For more detail, see here.
December 14, 2014
"Blood Test Innovation: Less Cost, No Big Needle"
Information Week/Healthcare. By Larry Stofko. Here.
For further details, see here.
December 8, 2014
"Here's How the World's Youngest Self-Made Female Billionaire Shows People She's In Charge."
Business Insider. By Richard Feloni. Here.
December 8, 2014
"The New Yorker on the Promise, the Secrecy, and the Challenges of Super-Startup Theranos."
MedCityNews. by Meghana Keshavan. Here.
December 12, 2014
"Behind the Curtain at Theranos."
NBC News. (Video). Interview with Ken Auletta. Here.
For more detail, see here.
December 14, 2014
"Blood Test Innovation: Less Cost, No Big Needle"
Information Week/Healthcare. By Larry Stofko. Here.
December 15, 2014
"Blood, Simpler."
New Yorker - By Ken Auletta. Here.
|
Two letters from readers, 1/2015, published here.
December 15, 2014
"Theranos and the Biopolitics of Blood Testing."
New APPS: Arts, Politics, Philosophy, Science. By Gordon Hull. Here.
December 17, 2014
"New Yorker: Theranos' founder's description of chemistry process 'comically vague.' "
Pathology Blawg. Here.
Over 15 comments available.
December 26, 2014
"Bay Area Startups Theranos, HealthTell Are Out for Blood."
SFGate. By Stephanie M. Lee. Here.
Compares Theranos and HealthTell. Healthtell webpage, here [A New Era in Medicine.]
December 29, 2014
"Elizabeth Holmes: Milionara que Quiere Revolucionar el Sistema Sanitorio Americano."
Es.Blastingnews/Salud-Belleza. By Lidia de Marco. Here.
Also in Spanish see also: BBC/Mundo/ August 15, 2014, here.
January 5, 2015
"Legal Update: Nanotainer vs Microtainer; Theranos Sues Becton Dickinson."
After receiving complaints from BD on its "Microtainer" trademark, Theranos sues
for a ruling that "Nanotainer" does not infringe on "Microtainer."
January 8, 2015
"Consumering Medicine: Are Patient-Initiated Blood Tests the Future?"
Vector: Boston Childrens Hospital Blog. By Erin Horan. Here.
January 9, 2015
"How Technology Will Eat Medicine."
Wall Street Journal [Blog]. By Vivek Wadhwa. Theranos cited. Here.
January 14, 2015
"Cette femme est devenue milliardaire grâce à... une prise de sang."
JDN/L'economie demain. By Kevin Loria, trans. F. Wittner. Here.
January 26, 2015
"Did Theranos Turn Over Its CLIA Lab Director?"
Dark Report (Subscription only).
January 28, 2015
"Elizabeth Holmes, Theranos: Transforming Healthcare by Embracing Failure."
Youtube. Stanford Graduate School of Business. Here.
February, 2015
"Top 10 Most Innovative Companies in Health Care, 2015: #7, Theranos"
Fast Company (staff), here.
February, 2015
"Vetting Theranos"
Laboratory Economics [trade journal, subscription]. By JonDavid Kipp. Here.
February 2, 2015.
"CEO Q&A: Craig Hall."
Real Estate Daily. By Christina Perez. Hall was early investor in Theranos. Here.
February 3, 2015
"Breakthrough Branding: Theranos, with Walgreens, Revolutionizes Healthcare."
Brand Channel. By Sheila Shayon. Here.
February 3, 2015
"Will Theranos Turn the Lab Industry Upside Down?"
February 6, 2015
"Ten Things to Know about America's Youngest Female Billionaire."
Business Insider. By Koa Beck. Here.
February 5, 2015
"Disruptive Technology Main Focus at Clinton Health Conference."
California Healthline. By Lauren McSherry. Here.
President Clinton, Fourth Annual Health Matters Activation Summit. "Access to health information is a basic human right," said Elizabeth Holmes, a young Silicon Valley entrepreneur who founded Theranos, a blood analytics and diagnostics company. [President] Clinton, who applauded her work to provide low-cost testing to the general public, said the company is valued at $9 billion. See also at Clinton Foundation.org, here.
February 10, 2015
"Elizabeth Holmes - Theranos"
Upstart. By Teresa Novellino. Here.
February 10, 2015
"Theranos CEO: Avoid Backup Plans."
INC (from Stanford Business School.) By Deborah Peterson. Here.
"I think that the minute that you have a backup plan, you've admitted that you're not going to succeed."
February 17, 2015
"Stealth Research: Is Biomedical Innovation Happening Outside the Peer-reviewed Literature?"
JAMA. By John P.A. Ionnanidis. Here.
"Theranos is just one example among many for which major efforts and major claims about biomedical progress seem to be happening outside the peer-reviewed scientific literature...stealth research creates total ambiguity about what evidence can be trusted in a mix of possibly brilliant ideas, aggressive corporate announcements, and mass media hype." See comment at Healthnewsreview.org here (February 23, 2015).
February 27, 2015
"Tech company Theranos pushes consumer lab-testing bill."
Arizona Republic. By Ken Tucker. Here.
For legislative text, here. For a blog on the topic, here. For cloud version of the legislative text, here. Article in March 2015 Laboratory Economics [subscription, here.]
February, 2015
"Theranos: Blood Tests that Need Just a Tiny Sample."
Walgreens website, "At the Corner of Happy and Healthy," accessed 2/17/2015. Here.
March, 2015
"Secret Shoppers Disappointed by Theranos."
Laboratory Economics. By Jondavid Klipp. Here (subscription).
Summarizes experiences of "secret shoppers" from Piper Jaffray, an Arizona lab, The Dark Report, and a California lab. Most reported 3-day results and many reported standard venipuncture.
March 2, 2015
"Meet the Most Impressive Woman on Forbes' Female Billionaire List."
Identities.Mic. March 2, 2015. By Julie Zeilinger. Here.
March 5, 2015
"Millennials and Money: New Kids in the Forbes Billionaires Club."
National Center for Business Journalism. By Rian Bosse. Elizabeth Holmes noted. Here.
March 6, 2015
"Theranos Files Comment In Support Of Food and Drug Administration Oversight Of Laboratory-Developed Tests."
Theranos Press Release. Here.
The comment letter, dated 3/1/2015, 4 pages, here.
March 7, 2015.
"Health care in America: Shock treatment. A wasteful and inefficient industry is in the throes of great disruption."
March 9, 2015
"Theranos and Cleveland Clinic Announce Strategic Alliance to Improve Patient Care through Innovation in Testing."
Press release. Here.
March 9, 2015
"Cleveland Clinic Taps Theranos, Bets on Cheaper Diagnostics."
Healthcare Finance News. Anthony Brio. Here.
March 9, 2015.
Fox News Cleveland Clinic/Theranos Interview. VIDEO.
March 9, 2015
"Cleveland Clinic Enters 'Long-Term Strategic Alliance' with Theranos, Inc."
Crain's Cleveland Business. By Timothy Magaw. Here.
March 9, 2015
"Elizabeth Holmes: 2015 Horatio Alger Award Winner."
March 13, 2015
"Theranos Seeks FDA Approval for Early-detection Ebola Test: George Schultz."
Silicon Valley Business Journal. By Ben Soriano. Here.
March 17, 2015
"Mark Cuban Talks Healthcare Investing: Soon Our Bodies Will Be Big Math Equations."
MedCity News. By Stephanie Baum. Here.
“Sensors are the next opportunity,” Cuban said. He also voiced his enthusiasm for companies like 23andMe and Theranos.
March 23, 2015
"Boies Schiller Set to Open Palo Alto Outpost."
The Recorder. By Patience Haggin. Here.
Litigation partner Parker Bagley will head the office....relocated from the firm's New York office...busy on a trademark case for medical-technology company Theranos Inc.
April 7, 2015
"Patients Can Soon Get Lab Tests Without Doctors' Orders."
Arizona Republic. By Yvonne Wingett Sanchez & Ken Alltucker. Here.
April 8, 2015
"Theranos One Step Closer to Consumerizing Health."
Decibio [Blog]. By Eric Lakin. Here. [Arizona consumer test law.]
April 9, 2015
"Arizona Health Law Could Boost Theranos' Biotech Prospects."
USA Today [America's Markets]. By Marco Della Cava. Here.
April 16, 2015
"Elizabeth Holmes."
TIME [100 Most Influential People.] By Henry Kissinger. Here.
April 17, 2015.
"How Elizabeth Holmes became inspired to transform blood testing." VIDEO
April 20, 2015
"The Doctor is Out: LabCorp to Let Consumers Order Own Tests."
Bloomberg. By Cynthia Koons. Here.
Also: In slightly different version, same author, Bloomberg Business Week, 4/27/15.
Also: At FierceDiagnostics, here.
April 20, 2015
"What News at Theranos? Lab Firm Expands in AZ."
"In Arizona, New Consumer Direct Access Law is a First Win for California-Based Theranos."
"Theranos: Many Questions, but Very Few Answers."
Dark Report (subscription). Here.
April 25, 2015
"Scientists are Skeptical about the Secret Blood Test that has made Elizabeth Holmes a Millionaire."
BusinessInsider. By Kevin Loria. Here.
Mentioned by Wall St Journal blog, Pharmalot (here).
Loria quoting Theranos, "We've been submitting all of our tests to [FDA]." Since FDA 510(k) review time is 138 days (here), and since are all published, a lot of clearances should appear on the FDA website.
April 27, 2015
"World's Youngest Billionaire - Another Steve Jobs?"
CNBC. By Abigail Stevenson. Here.
April 27, 2015
"Occam's Razor and the Secrecy of Theranos. A Bunch of Crock? No."
Medcitynews. By Meghana Keshavan. Here.
April 28, 2015
"Guest List, State Dinner, Prime Minister Shinzo Abe, Japan."
Washington Post. Here. (Including Ms. Holmes.)
April, 2015
Arizona Direct Access Laboratory Test Bill 2645 (Text).
Here. "Laboratory Testing Without Order."
(To be confirmed if this is the final Arizona text).
- Note that some FDA approved laboratory tests state "device by physician prescription only."
- HIPAA was revised in early 2014 to allow easier direct access to lab reports under federal law, but did not revise test ordering law. Here, here, here.
- Not directly related to Thernanos, but related to falling test price and consumer purchases, Color Genomics has introduced a $249 test for BRCA and 17 other genetic variants, with the idea they are bringing this testing into the range of consumer self-purchase. For one entry point, see NPR, 4/21/2015, here.
April, 2015
"Arizona Expands Direct Access Testing."
Laboratory Economics. By Jondavid Klipp. Here. (Subscription).
"Adam Rosendorff MD resigned from his position as Theranos' laboratory director...now working as laboratory director at Invitae, Inc....Theranos recently promoted Christian Holmes to the position of director, commercial operations." (Linked-In).
May 4, 2015
"Theranos Selects Phoenix Metro to Plant Its Flag and Enter the Competitive Market for Clinical Pathology Laboratory Testing."
Dark Daily. Here.
May 4, 2015
"Epiphany." [Short Film; Blog] VIDEO
Theranos. By Elizabeth Holmes. Here. Video (1:15 min).
As of May 18, 2015, there were six short films by Errol Morris on the Theranos Youtube channel, here. See also: May, 2015, Laboratory Economics (subscription), "Theranos Hires Film Maker for Youtube Commercials." Here.
May 5, 2015
"Theranos Sticks It to Critics, Plans Expansion of Lab Services."
San Francisco Business Times. By Ron Leuty. Here.
"Can Theranos Disrupt the Clinical Lab Testing Market? An Objective Look at Advantages, Liabilities, and Challenges That Must Be Addressed."
[Pathology] Executive War College. By Dr. Robert Boorstein. [Deck] Here.
"Can Theranos Disrupt the Clinical Lab Testing Market? An Objective Look at Advantages, Liabilities, and Challenges That Must Be Addressed."
[Pathology] Executive War College. By Dr. Robert Boorstein. [Deck] Here.
May 7, 2015
"Theranos Jump Starts Consumer Lab Testing."
Fortune. By Ron Parloff. Here.
"My last routine blood tests, drawn at my physician’s office...cost me $433 out of pocket, even after application of my “gold”-level insurance....Had I not been insured, the lab’s price for those tests would have been $2,411, according to the explanation of benefits sent me. The same tests, according to Theranos’s price menu, would have cost me $75."
May 7, 2015
"New Laboratory Testing Firm Seeks to Shatter Old Diagnostic Testing Model."
Genomeweb. Here.
May 7, 2015
"Silicon Valley Lab Testing Startup Hires Clinton Advisor."
May 11, 2015
"Our Editor Describes Visit to Theranos Test Center."
Dark Report. (Subscription). Here.
Sidebar: "Comparing Patient Visit with Advertised Benefits."
May 11, 2015
"Airbnb Chesky, Theranos Holmes among presidential entrepreneurs."
USAToday. By Marco della Cava. Here.
Winners met with Commerce Secretary Penny Pritzker and President Obama.
May 11, 2015
"Elizabeth Holmes on Joining the Presidential Ambassadors for Global Entrepreneurship Initiative."
Theranos/news/posts. By Elizabeth Holmes. Here.
May 11, 2015
"HealthTell’s marketing language jabs at Theranos (also, it’s raising $5M for its own single-drop-of-blood diagnostics)."
MedCityNews. By Meghana Keshavan. Here.
May 16, 2015
"Revolution mit einem Tropfen Blut."
[Revolution with a Drop of Blood.]
Handelsblatt. By Elke Binder. Here.
May 21, 2015.
"My secret weapon: How a virtual assistant changed my life."
Fortune. By Leigh Gallagher. Here.
Gallagher interviews Maren Donovan, founder of Zirtual Inc; Donovan admires Elizabeth Holmes.
May 28, 2015
"She's Bold, She's Beautiful, and She's a Self-Made Billionaire."
New York Post. By Staff. Here.
May 29, 2015
"mHealth: Counting on Consumers to Fuel Innovation."
mHealthNews. By Eric Wicklund.
Interview: Q: What mHealth technology will become ubiquitous in the next 5 years? A: I think the technology from Theranos has the greatest potential and will be near ubiquitous. This chip-based technology allows a person to have any of 70 common lab tests for $2-$5 from just a drop of blood.
June 2, 2015.
Elizabeth Holmes: Charlie Rose. VIDEO.
Here. Comment, Kevin Loria, June 4, 2015.
June, 2015
"Collecting More Dollars From Patients:
Why It’s Time For Clinical Labs and Pathology Groups to Move To The Retail Model."
Dark Report [Trade journal, white paper]. Here.
This white paper does not mention "Theranos" but covers the topic of retail access to laboratory tests.
June 5, 2015
"Elizabeth Holmes still won't explain how her $9 billion technology actually works."
Business Insider. By Kevin Loria. Here.
June 8, 2015
"Theranos CEO Props Up Testing Modeling at AHIP, Targets States Blocking Access."
Healthcare Finance News. By Anthony Brino. Here.
June 11, 2015
"Is Theranos Procedure a Healthcare Industry Revolution or a Marketing Phenomenon?"
MedicalXPress.com. Here. Press release for Diamandis, "Promises and Fallacies," next.
June, 2015
"Theranos phenomenon: promises and fallacies."
Diamandis EP. In: Clinical Chemistry and Laboratory Medicine (CCLM).
Volume 53, Issue 7, Pages 989–993, DOI: 10.1515/cclm-2015-0356.
At Pubmed (PMID 26030792): here.
Full academic article on line, open access, here (html); see page for "Full Text PDF" button.
See also June 26, 2015, Business Insider, below.
June 19, 2015
"Personalized Technology Will Upend the Doctor-Patient Relationship."
Harvard Business Review. By Sundar Subramanian et al. Here.
June 21, 2015
"The Benefits to Your Brain of a Work Uniform."
Providence Journal [Chicago Tribune]. By Alexia Elejalde-Ruiz. Here.
June 22, 2015.
"With Carlos Slim, Billionaire Elizabeth Holmes Brings Innovative Blood Testing Method To Mexico."
Forbes. By Dolia Estevez. Here.
June 23, 2015
"Theranos' New Deal with Billionair Carlos Slim May Take It to Another Level."
Biz Journal SF. By Ron Leuty. Here.
June 26, 2015
"A Scientist Just Raised Four Serious Questions about the Blood Test that Made Elizabeth Holmes a Billionaire."
Business Insider. By Kevin Loria and Lauren F. Friedman. Here.
June 27, 2015.
"Young Blood. Theranos, an Ambitious Silicon Valley Firm, Wants to Shake Up the Market for Blood Testing."
The Economist. Here.
and
"Elizabeth Holmes: Holmes Is Where the Heart Is."
The Economist. Here.
July 2, 2015.
"Startup Theranos Cleared by FDA for Fingerprick Herpes Test."
Bloomberg News. By Caroline Chen. Here.
Note: the FDA clearance triggered 50+ articles.
Theranos Press Release, here.
See also Theranos' March 6, 2015 support for FDA regulation of lab developed tests [above].
July 2, 2015
"Controversial Multibillion-Dollar Health Startup Theranos Just Got a Huge Seal of Approval from the US Government."
Business Insider. By Laren F Friedman. Here.
July 2, 2015
"Disruptive Diagnostics Firm Theranos Gets Boost from FDA."
Fortune. By Roger Parloff. Here.
July, 2015
510(k) Substantial Equivalent Summary: [Theranos] Herpes Simplex Virus-1 IgG Assay.
July 3, 2015
"Theranos Blood Test: The Insanely Influential Stanford Professor Who Called the Comapny Out for its 'Stealth Research.' "
Washington Post. By Ariana Eunjung Cha. Here.
July 4, 2015
"Arizona Law Co-Authored by Theranos Is Going Into Effect."
MarketBusiness. Here.
July 5, 2015
"Freedom to Get Lab Tests Ushers in Better Health Care."
AZ Central [Arizona Republic/Gannett]. By Elizabeth Holmes. Here.
July 6, 2015
"Theranos Gets Unnecessary FDA Approval for its Cheap, Fingerstick Blood Tests."
MobiHealthNews. By Jonah Cornstock. Here.
July 8, 2015
"Theranos Strikes Deal with Capital BlueCross, Lands on East Coast."
HealthcareFinanceNews. By Anthony Brino. Here.
July 15, 2015
"A Look Inside the Insanely Successful Life of Elizabeth Holmes, the World's Youngest Self-Made Female Billionaire."
Business Insider. By Maya Kosoff. Here.
July 16, 2015
"Running a Few Tests: Can Elizabeth Holmes Revolutionize Diagnostics?"
Forbes. By Matthew Herper. Here.
July 16, 2015
"Theranos Inks Medicaid Deal and Snags CLIA Waiver to Expand Dx Reach."
FierceDiagnostics. By Emily Wasserman. Here.
Deal with AmeriHealth Caritas [ 16 states; in part Medicaid.]
July 16, 2015
"Theranos Receives CLIA Waiver, Paving the Way for Greater Accessibility of Health Information at the Time and Place it Matters."
"First Ever CLIA Waived HSV Test and Test System."
FierceDiagnostics [Press Release]. Here.
"The waiver categorization therefore allows Theranos to operate its technology both within its CLIA certified laboratories and also within locations outside of its certified laboratories, including Theranos Wellness Centers..."
July 20, 2015
"How Much Does Theranos' Power Packed Board Help It Navigate DC?"
San Francisco Business Times [Bizjournals.com] By Ron Leuty. Here.
July 21, 2015
"The Tech World's Blood-Test Darling Gets Nods from the FDA."
Wired. Here.
July 22, 2015
"ASU Offers Lab Tests in First University Partnership with Theranos."
State Press [AZ] By Elizabeth Castillo. Here.
July 24, 2015
"Biden Visits Theranos Lab as Part of Healthcare Innovation Summit"
USAToday. By Marco della Cava. Here.
July 24, 2015
"Theranos Pushing Direct to Consumer Blood Testing."
Health IT Outcomes. By Christine Kern. Here.
July 30, 2015
"Theranos’ Holmes Marks 50th Anniversary of Medicare and Medicaid with Vision for Next 50 Years."
Business Wire [press release]. Here.
August 11, 2015
"Nickles Takes On Theranos."
O'Dwyer PR Inside News, here. (Nickles is a Washington policy group).
August 17, 2015
"A Good Month for Blood."
Laboratory Equipment. By Michelle Taylor. Here.
August 19-20, 2015
"Leveraging Pharmacies for Rapid Diagnostics."
7th Annual Next Generation Diagnostics Summit (Two-Day Track on Pharmacies).
While not specific to Theranos, a two-day meeting on lab tests in the pharmacy space.
August 24, 2015
"Labcorp is Reaching Past Doctor's Office to the Patient."
Investors Business Daily. By Gillian Rich. Here.
August 25, 2015
"Why Practice Fusion And Theranos Will Disrupt Lab Testing On Electronic Health Record Platforms."
Forbes. By Robert Glatter MD. Here. At HealthIT: Here. Practice Fusion is a cloud based EHR system which has garnered $157M in venture capital.
"Why Practice Fusion will be One Exciting IPO," at Nanalyze, September 7, 2015, here.
August 31, 2015
"Theranos' Elizabeth Holmes And Top Executives To Reimagine Healthcare At The Forbes Healthcare Summit."
September, 2015
"Theranos: Food for Thought."
DisruptiveInsightsGroup. Here.
And: September 17, "Following Successful Theranos Research Report, Firm Takes Aim at Healthcare "Blind Spot" With New Website and Product Set." Here. Report $2500-7500, here.
September 10, 2015
"Consumer Blood Test to Detect Cancer Hits Market"
Bloomberg. By Caroline Chen. Here.
(Pathway Genomics in San Diego offers DTC liquid biopsy testing that screens for cancer. Cites Theranos as another DTC approach and regarding the vigor of the DTC lab space.)
"Pathway, based in San Diego, is joining a wave of health startups offering tests for healthy consumers at affordable prices, often bypassing insurance coverage. Some, such as Color Genomics Inc. and 23andMe Inc., tell consumers their genetic susceptibility to certain diseases. Others, like Theranos Inc., are encouraging consumers to keep track of general fitness through regular monitoring of basic metrics such as cholesterol."
September 21, 2015
"Internationally-respected Experts in Clinical Pathology and Laboratory Medicine Ask: Why Don’t We Know More about Theranos’ Technology?"
Dark Daily. Here.
October 1, 2015
"This Technology Firm was Named Arizona's Bioscience Company of the Year."
Phoenix Business Journal. By Angela Gonzales. Here.
October 2, 2015
"What Technology Can Do for Your Health."
Financial Times. By Gillian Tett. Here.
October 5, 2015
"Elizabeth Holmes on Using Business to Change the World."
Forbes. By Sarah Hedgecock. Here.
October 6, 2015
"Self Made Billionaire on Re-inventing Blood Tests: It's Like Cocaine."
Vanity Fair. By Emily Jane Fox. Here.
October 6, 2015
"How Theranos is Disrupting the Health Care Industry."
Bloomberg. [VIDEO 6:38 min.] Here.
"A cholesterol test is $2.99, whereas it could cost hundreds in other locations...The response from the lab industry, they have so aggressively seeded false information about us into the press, into journalists, into physicians in the market we are in."
October 7, 2015
"Theranos Founder Elizabeth Holmes to Deliver Keynote Address at 2015 Medical Innovation Summit."
Craigs Cleveland Business. Here.
October 12, 2015
"Theranos' Elizabeth Holmes Call on Women to Help Each Other."
Fortune. By Michael Lev-Ram. Here.
October 12, 2015
"CME Group Announces Elizabeth Holmes as the 2015 Melamed-Arditti Innovation Award Receipient."
MarketWatch. Here.
|
"Hot Startup Theranos Has Struggled
With Its Blood-Test Technology."
WSJ. By John Carreyrou. Here.
|
October 15, 2015
"Theranos, One of the Hottest New Biotech Startups, Has a Huge Credibility Problem."
Vox. By Julia Belluz. Here.
October 15, 2015 [10 pm]
"Hot Startup Theranos Dials Back Lab Tests at FDA’s Behest."
WSJ. By John Carreyrou. Here.
"Under pressure from regulators, laboratory firm Theranos Inc. has stopped collecting tiny vials of blood drawn from finger pricks for all but one of its tests, according to a person familiar with the matter, backing away from a method the company has touted as it rose to become one of Silicon Valley’s hottest startups....Food and Drug Administration inspectors recently showed up unannounced at Theranos....During the inspection, FDA officials indicated to Theranos that the agency considers the “nanotainers” made and used by the company to collect finger-pricked blood an unapproved medical device, the person familiar with the matter said. Theranos founder Elizabeth Holmes said in an interview on the CNBC show “Mad Money” that the company is “not even using our nanotainers except for FDA-cleared assays.”
October 15, 2015
"Theranos Scandal Exposes the Problem with Tech's Hype Cycle."
Wired. Issue Lapowski. Here.
"Theranos' Elizabeth Holmes Needs to Stop Complaining and Answer Questions."
Forbes. By Matthew Herper. Here.
"The Wildly Hyped $9B Blood Test Company that No One Really Understands."
Washington Post. By Carolyn Y. Johnson. Here.
"Theranos' Board: Plenty of Political Connections, Little Relevant Expertise."
Fortune. By Jennifer Reingold. Here.
Theranos' CEO Fires back at WSJ: I Was Shocked."
CNBC. Here.
"Lab Company That Touts Dual FDA/CMS Review Model For LDTs Allegedly Probed By Both Agencies."
Inside Health Policy, By Joe Williams. Here.
As previously reported by Inside Health Policy, Theranos recently hired lobbyists to advocate for FDA regulation of LDTs. While sources told IHP the company was initially lobbying in support of a proposal from the Diagnostic Test Working Group, a working group of large reference laboratories and manufacturers, Theranos denied these claims.
"Theranos is not lobbying in support of the DTWG proposal. With regard to LDT quality and the FDA, we believe that doctors and patients deserve results they can trust as they make some of the most important decisions of their lives. We believe it is critical that quality standards for lab tests not be compromised. We also believe that ensuring every company and every lab can operate on a level playing field with transparent, consistent, clearly defined standards and regulations is critical to fueling innovation," a spokesperson for the company told IHP at the time.
October 18, 2015
"Some tech investors seem to be getting defensive."
Business Insider. By Matt Rosoff. Here.
"Theranos Trouble: A First Person Account."
MondayNote. by Jean-Louis Gassee. Here.
"Disruptive Bloodwork Startup May Be Mostly Vaporware."
SlashDot. Here.
October 19, 2015
"Lab Test Firm Theranos Offers Weak Rebuttal to WSJ Charges."
ValueWalk. By Clayton Brown. Here.
"Sequoia's Michael Mortiz Singles Out Theranos in Warning on Sub Prime Unicorns."
Silicon Valley Business Journal. By Cromwell Schubarth. Here.
"It is easier to conceal weaknesses, present an aura of invincibility and confound investors as a private company that can escape by making fewer disclosures, than as a publicly traded one."
"Early Theranos Investor Remains Supportive Even Without Answers."
Bloomberg. By Caroline Chen. {re: Steve Jurvetson} Here.
"Why Google Ventures Didn't Invest in Theranos."
Business Insider. By Jillian D'Onfro. Here.
October 20, 2015
"Fixing the Laws that Let Theranos Hide Data Won't Be Easy."
Wired. Here.
"The Theranos Controversy Explained."
Vox. Julia Belluz. Here.
October 21, 2015
"Thernanos CEO Elizabeth Holmes Goes on Stage at WSJ Digital Live 2015."
Live Blog. Here.
"Theranos CEO Elizabeth Holmes Punches Back Against the WSJ"
Fast Company. By Harry McCracken. Here.
"Theranos CEO Elizabeth Holmes Fires Back at Report Attacking Her Company's Blood-testing Tech."
Venture Beat. By Mark Sullivan. Here.
Overseas:
"Sanglante Accusation Contre la Startup Theranos." [October 16]
Cyceon. Here.
"La Heroina de los Analysis de Sangre se Enfrenta a un Fracaso Multimillionario." [October 20]
Noticias. By Juan Carlos Saloz. Here.
"Sie ist die Jungste Milliardarin der Welt: Doch an Ihrer Erfindung Gibt es Zweifel." [October 20]
Grunderszene. By Hannah Loffler. Here.
October 22, 2015
"What Is Theranos' Business Model Anyway?"
Forbes. By Frank David. Here.
October 23, 2015
"Theranos blood labs under fresh scrutiny on staffing and quality."
Financial Times. By David Crow & Adam Samson. Here. [Long; 1700 words]
"Silicon Valley: $9B Theranos Threatened With Extinction."
Breitbart. By Chriss W. Street. Here.
October 23, 2015
"Theranos blood labs under fresh scrutiny on staffing and quality."
Financial Times. By David Crow & Adam Samson. Here. [Long; 1700 words]
"Silicon Valley: $9B Theranos Threatened With Extinction."
Breitbart. By Chriss W. Street. Here.
October 24, 2015
"Walgreens Halts Expansion of Theranos Bloodwork Centers."
USAToday. By Marco della Cava. Here.
"Walgreens Puts the Brakes on Theranos Roll Out. Are Lawsuits Next?"
Fortune. By Dan Munro. Here.
"After Damning Report, Walgreens Tables Plans to Expand Theranos Blood Testing Centers Nationwide."
International Business Times. By Elizabeth Whitman. Here.
"A Look at the Underbelly of Theranos."
Medcitynews. By Meghana Keshavan. Here.
"A Look at the Underbelly of Theranos."
Medcitynews. By Meghana Keshavan. Here.
October 26, 2015
"Theranos CEO Elizabeth Holmes's Five Best Cover Story Appearances."
Recode.net By Noah Kulwin. Here.
"Theranos Didn't Work with the Huge Drug Company It Supposedly Made Money From, Huge Drug Company Says."
The Verge. By Arielle Duhaime-Ross. Here.
October 27, 2015
"Theranos Chief Yields to Calls for Proof of Blood Test's Reliability."
New York Times. By Andrew Pollack. Here.
"The FDA Posted Its Inspection Reports for Theranos. They Don't Look Good."
October 28, 2015
"Theranos, Facing Criticism, Says It Has Changed Board Structure."
New York Times. By Andrew Pollack. Here.
The Management Board of Theranos issued a statement in support of Ms. Holmes and Theranos: “Theranos is a revolutionary business, founded and led by a remarkable engineer and businesswoman — joined by a team of professionals who have, at their core, embraced her mission to serve humanity through innovation in health care.” The Management Board of Theranos is composed of Ms. Holmes, her attorney, and her COO. The Management Board has two additional members, construction executive Riley Bechtel and Genl. Mattis of the Marine Corps (ret.).
October 29, 2015
"The Narrative Frays for Theranos and Elizabeth Holmes."
New York Times. Here.
"This Is What We Should Learn From Theranos."
Forbes. By Ramzi Amri. Here.
"The Theranos Scandal Could Become a Legal Nightmare."
Wired. By Nick Stockton. Here.
"Conflict of Interest in T Magazine Tech Article."
"The Theranos Scandal Could Become a Legal Nightmare."
Wired. By Nick Stockton. Here.
"Conflict of Interest in T Magazine Tech Article."
New York Times [Public Editor]. By Margaret Sullivan. Here.
Quote:
This is a case in which the financial conflict is so clear, and the spousal tie so close, that a disclosure would not have been enough. A different writer altogether would have been a far better idea, and, to my mind, the only right one.What’s more, the article was extremely favorable to these “most visionary entrepreneurs.” In fact, one of them, Elizabeth Holmes, was also hailed as one of “The Greats” in the same issue. (She, along with ... Quentin Tarantino... was described in a headline as “Greatness, Personified.”) In contrast, only days later, Ms. Holmes was the subject of a tough-minded Wall Street Journal investigation into the serious problems of her company, Theranos. That kind of exposé is not T’s mission, of course, but the magazine is still part of The Times’s journalistic offerings, and should live by the same standards.Online, the article now carries a disclosure about Mr. Andreessen and a link to news coverage of Theranos, and an editors’ note has appeared in print.[This editor's notice has 216 comments as of 4/2016.]
[See Patrick Coffee article, April 14, 2016, below.
October 30, 2015
"Theranos' Groundbreaking Approach Isn't Breaking Much New Ground."
Washington Post. By Carolyn Y. Johnson. Here.
"Theranos Battled in Courtroom Over Name of Its Chief Product."
New York Times. By Katie Benner. Here.
Starting late last year, Theranos and Becton, Dickinson & Company, a medical equipment maker ...were embroiled in dueling trademark lawsuits over similarities between the nanotainer and BD’s “microtainer,” which is also used to collect blood. While the nanotainer began to draw a lot of attention in 2013 and is seeking regulatory approval, microtainers have been around for at least 45 years and are approved by the Food and Drug Administration. In court documents from last November, BD asserted that Theranos had “the intent to trade off of the significant good will that BD has established in its microtainer mark....”
October 31, 2015
"The Fable of the Unicorn: A Much-hyped Medical Startup is Suddenly Plagued with Doubts."
The Economist. Here.
The Theranos Mess: A Timeline.
Fortune. By Dan Primack. Here.
(The timeline primarily spans October 15-30).
"These Researchers Were Onto Theranos Long Before the Mainstream Media."
Vox. By Julia Belluz. Here.
"Blood-Testing Startup Theranos, Inc. Is Trading Blows With the Wall Street Journal."
Legal Broadcasting Network. By Cecil Caulkins. Here.
November 2, 2015
"Why the Story Failed at Valeant and Theranos."
Bloomberg. By Barry Ritholtz. Here.
"Beware the Hype Machine. Lessons from Theranos."
Forbes. By Chris Myers. Here.
"Theranos' Elizabeth Holmes Says Company Will "Absolutely" Get FDA Approval."
Fortune. By Jennifer Reingold. Here.
November 3, 2015
"Theranos Letter Shows Elizabeth Holmes Tried to Take Control from Shareholders."
Forbes. By Peter Cohan. Here.
"Theranos CEO Admits Her Company Has a Communication Problem."
Gizmodo. By George Dvorsky. Here.
"Q&A: Regulatory Expert Karen Becker Provides Context for Theranos, FDA Interactions."
Genomeweb [subscription]. By Turna Ray. Here.
"Theranos' Holmes Promises More Transparency."
USA Today. By Marco della Cava. Here.
"Theranos' Holmes Promises More Transparency."
USA Today. By Marco della Cava. Here.
November 4, 2015
"Firefox Founder Writes Original Screenplay Called ‘PRICKS’ Brutally Parodying Theranos."
Techcrunch.com By Lucas Matney. Here.
November 6, 2015
"Theranos is Looking for a New Lab Director in California."
Fortune. By Valentina Zarya. Here.
(Also: WSJ, November 5, here.)
The lab’s current director is Sunil Dhawan, a dermatologist with no background in laboratory science.
Technically, since Dr. Dhawan is a medical doctor and has experience supervising a lab (Theranos said he has overseen the lab affiliated with his dermatology practice for two decades), Dr. Dhawan meets federal and state requirements to lead a lab.
"When you consider the complexities of a reference lab...it would be next-to-unheard of to have anything less than a full-time pathologist or laboratory scientist with a Ph.D. as the laboratory director,” Ed Thornborrow, medical director of the clinical labs at the University of California, San Francisco told the [WSJ].
November 10, 2015
"Redefining Diagnostics: An Industry View."
The Hill.com By Cary Gunn (Genomics CEO). Here.
"23andMe Cofounder Has a Message for Theranos: Show the Data."
Tech Insider. By Melia Robinson. Here.
"Theranos, Safeway Split After $350M Deal Fizzles."
WSJ. by John Carreyou. Here.
"Safeway Inc. spent about $350 million to build clinics in more than 800 of its supermarkets to offer blood tests by startup Theranos Inc. But the tests never began, the clinics are now used largely for flu shots and travel-related vaccines, and the two companies have been negotiating to officially dissolve their partnership, according to people familiar with the matter. Current and former Safeway executives said Theranos missed deadlines for the blood-testing rollout. They also said several Safeway executives questioned the accuracy of results Theranos gave to Safeway employees tested at a clinic in the supermarket chain’s headquarters in Pleasanton, Calif."
November 11, 2015
"Entrepreneur Builds a Leading Chain of Diagnostics Labs."
WSJ. By Karan Deep Singh and Shannon van Sant. Here.
WSJ. By Karan Deep Singh and Shannon van Sant. Here.
Re: Ameera Shah; Metropolis Healthcare; built her father's business in to a 3800 employee laboratory chain in India.
"Theranos isn't the Only Lab Exploiting Regulatory Loopholes."
The Verge. By Arielle Duhaime-Ross. Here.
"Wojcicki: Theranos Not Required To Be Transparent."
Bloomberg Video (2 min). Here.
November 17, 2015
"Learn From Theranos’s Mistakes: An Analysis of the Form 483s (Part I)"
MDDI Device Talk. By David Amor. Here.
November 20, 2015
"Is Theranos' Blood Testing for All a Responsible Selling Proposition?"
Telecareaware. By Donna Cusano. Here.
November 21, 2015
"IN Defense of Theranos."
Techcrunch. By Micah Rosenbloom. Here.
Techcrunch. By Micah Rosenbloom. Here.
November 23, 2015
"Quest Subsidiary [Sonora] is Safeway's Rebound After Theranos Breakup."
Modern Healthcare. Here.
November 24, 2015
"Theranos: Science Fact or Science Fiction?"
The Pathologist. By Roisin McGuigan. Here. [Free registration required].
November 24, 2015
"Theranos: Science Fact or Science Fiction?"
The Pathologist. By Roisin McGuigan. Here. [Free registration required].
November 30, 2015
"Arizona Inspectors Find Theranos Lab Issues."
AZCentral. By Ken Alltucker. Here.
AZCentral. By Ken Alltucker. Here.
RESPONSE:
"Theranos Tests Were Accurate, Reliable."
By Elizabeth Holmes. Here.
"Your Nov. 29 story on Theranos is misleading to Arizonans."
Editor: "The Arizona Republic stands by its story."
"Safeway Almost Made a Massive Deal With Theranos. Now It’s Teaming Up With Theranos’ Biggest Rival."
Slate. By Lydia Ramsey. Here.
"Rice University Researchers Publish Study about Variation in Drop-to-Drop Samples of Capillary Blood Collected by Fingerprick and Used for Clinical Laboratory Testing."
"The average percent coefficient of variation (CV) for successive drops of fingerprick blood was higher by up to 3.4 times for hemoglobin, 5.7 times for WBC count, 3 times for lymphocyte count, 7.7 times for granulocyte count, and 4 times for platelets than in venous controls measured using a hematology analyzer." [AJCP]
December 2, 2015
"Emails Reveal Concerns about Theranos' FDA Compliance Date Back Years."
December 3, 2015
"Surprise: Theranos CEO Says Company Is Doing More Tests Than Ever."
Forbes. By Dan Diamond. Here.
“There’s a lot of elements of our business we haven’t yet talked about because we’re not doing them.”
December 5, 2015
"Diagnosing Theranos."
Forbes. By Steve Brozak. Here.
Forbes. By Steve Brozak. Here.
December 10, 2015
"Can Elizabeth Holmes Save Her Unicorn?"
Bloomberg. By Sheelah Kolhatkar & Caroline Chen. Here.
Bloomberg. By Sheelah Kolhatkar & Caroline Chen. Here.
Cover story, December 14-20 issue, here.
"She determined that a vegan, macrobiotic lifestyle would allow her to “train” her body to work all the time and to function on very little sleep." See research and evidence, here.
"Elizabeth Holmes Hints at Sexism in Media Coverage."
Fortune. By Kristen Bellstrom. Here.
December 16, 2015
"Medtech Losers of 2015: Theranos."
Device Talk (MDDI). Here.
Device Talk (MDDI). Here.
"Theranos Puts Spotlight on Direct Access Lab Testing."
Cronkite News / Arizona PBS. By Claire Cleveland. Here.
December 17, 2015
"How Theranos Misled Me."
Fortune. By Roger Parloff. Here.
See also: "Theranos Fires Back at the Fortune Editor Who Said the Company 'Misled' Him." Business Insider. Here. Letter to Fortune by Brook Buchanon, Theranos. Here. See also: A Fortune essay about the Fortune Parloff article, "Did Theranos Mislead Fortune?" here.
December 19, 2015
"Theranos Faces a Test of Technology, and Reputation."
New York Times. By Reed Abelson & Julie Creswell. Here.
"Regulators Probe Complaints from Former Theranos Employees over Lab, Testing Practices WSJ."
FierceMedicalDevices [Summary] By Emily Wasserman. Here.
"U.S. Probes Theranos Complaints."
WSJ. By John Carreyyou. Here.
See also: December 22, 2015: "Anonymous Sources Used to Accuse Theranos," by Brooke Buchanan, VP Communications, Theranos. WSJ letter, Here. "It is not unusual for disgruntled and terminated employees in the heavily regulated health-care industry to file complaints in an effort to retaliate against employers..."
December 27, 2015
"At Theranos, Many Strategies and Snags."
WSJ. By John Carreyyou. Here.
December 29, 2015
"Hagens Berman Announces Investigation of Theranos, Inc., Relating to Representations Made to Investors."
Business Wire. Here.
"Silicon Valley is Confusing Psuedo-Science With Innovation."
The Verge. By Bene Popper and Elizabeth Lopatto. Here.
December 30, 2015
"Theranos' Proprietary Technology Wasn't Vetted by Federal Inspectors for Two Years."
The Verge. By Arielle Duhaime-Ross and Elizabeth Lopatto. Here.
January 4, 2016
"Theranos Director: Blood Tester Will Be Vindicated."
CNBN. By Matthew J. Belvedere. Here.
[Former Wells Fargo CEO]
"Theranos Jumps the Gun on Innovation, Pushes Proprietary Tech Without Proof: WSJ."
Fierce Medical Devices. By Emily Wasserman. Here.
"NOW Diagnostics is Using Quick Fingertip Price Blood Testing to Identify Disease, and it's Fully Approved (A Step Above Theranos?)"
MedCityNews. By Nicole Oran. Here.
January 6, 2016
"Kessler Topaz Meltzer & Check LLP Announce Investigation on Behalf of Theranos Investors."
PR Newswire. Here.
January 7, 2016
"What Theranos and 23andMe Teach Us."
PE Hub Network [Private Equity]. By Florence Comte MD. Here.
January 8, 2016
"Genalyte is Taking the Single Fingertip Blood Test to the Next Level (Yet Another Theranos Competitor.)"
MedCityNews. By Nicole Oran. Here. [See NOW Diagnostics, Jan. 4, above]
January 25, 2016
"Deficiencies Found at Theranos Lab."
Wall Street Journal. By John Carreyrou. Here.
January 28, 2016
"Theranos Lab Practices Pose Risk to Patient Health, Regulators Say."
"Could Theranos Go From Unicorn to Unicorpse?"
Forbes. By Chris Myers. Here.
January 29, 2016
"Time is Running Out for Theranos."
Bloomberg. Sheelah Kolhatkar. Here.
Bloomberg. Sheelah Kolhatkar. Here.
January 30, 2016
"Here's the Single Biggest Mistake Theranos Made."
Business Insider. By Lydia Ramsey. Here.
February 1, 2016
"Is Theranos Finished?"
STAT {Boston Globe} By Rebecca Robbins. Here.
STAT {Boston Globe} By Rebecca Robbins. Here.
"Why Theranos-Walgreens Relations Is on the Rocks."
Fox News. By Steve Tobak. Here.
February 2, 2016
"Theranos Continues to Dodge Opportunities to Validate Its Inventions."
The Verge. By Arielle Duhaime-Ross. Here.
"David Boies's Dual Roles at Theranos Set Up Conflict."
New York Times. By Steven Davidoff Solomon. Here.
"Theranos Has Yet to Begin a Promised Validation Study."
Fortune. By Roger Parloff. Here.
February 3, 2016
"Next 'Blow Up' for Theranos? The Company's Latest Legal Hire [from NYT]"
Fierce Medical Devices. By Emily Wasserman. Here.
February 4, 2016
"Theranos Hopes to Fix Its Problems With a...Writer?"
Wired. By David Alba. Here.
February 5, 2016
"Wunderkind Theranos's Future Is On the Line."
Politico Pro. By Darius Tahir. Here.
"Theranos Doomsday Clock: A Full Timeline of its Rise and Fall."
MedCityNews. By Meghana Keshavan. Here.
"Theranos Has a Week to Respond to Searing Report About Its Business."
Business Insider. By Lydia Ramsey. Here.
February 11, 2016
"Troubled Startup Theranos Faces Washington Reckoning."
Politico. By Darius Tahir. Here.
February 16, 2016
"How a Reporter Pierced the Hype Behind Theranos."
ProPublica. By Cynthia Gordy. Here.
February 19, 2016
"Silicon Valley Biotechs: Theranos Gave Us a Black Eye."
The Guardian. By Nellie Bowles. Here.
February 22, 2016
"Researchers Urge Caution: Blood Drops Can Differ Greatly."
Study by Bond et al., Amer J Clin Pathol, here.
Note: Though covered 2/22/2016 by NYT and Fast Company, this study has an "online epublication date" of 12/1/2015.
Also on 2/23/2016 by Emily Wasserman in Fierce Medical Devices, here.
February 29, 2016
"Walgreens Is Reportedly Taking Steps to Dump Theranos."
Forbes. By Phil Wahba. Here.
March 3, 2016
"Theranos Elizabeth Holmes Withdraws from Conference Talk."
Medscape. By Damian McNamara & Allison Shelley. Here.
[Withdraws from Scripps annual genomic medicine conference.]
"Elizabeth Holmes Backs Out of Genome Medicine Conference"
San Diego Newspaper Group. Here.
March 8, 2016
"Theranos Ran Tests Despite Quality Problems"
"...81 Patients Despite Erratic Results from QC Checks"
WSJ. By John Carreyou. Here.
WSJ notes: "The test that inspectors found Theranos kept doing despite erratic QC results was a hematology test...Inaccurate results can be especially serious for patients taking blood things such as warfarin...too much warfarin can cause fatal bleeding.....The company has asked CMS not to publicly release the inspection report on the grounds that doing so would compromise Theranos trade secrets, according to people familiar with the company’s position. The agency usually makes inspection findings public after a period of time...."
"CMS Flogs Theranos for Quality Issues with Blood Clot Test"
Open Access comment at FierceMedical Devices, by Emily Wasserman, here.
March 9, 2016
"Why Much Hyped Biotech Company Is Fighting to Save its Reputation"
CBS News. Here.
CBS Video (6 minutes 26 seconds), same webpage.
March 11, 2016
"Theranos' Blatant Disregard for Patient Safety"
American Council on Science & Health. By Lila Abassi. Here.
March 14, 2016
"Hillary Clinton Lets Scandal-Plagued Corporation Throw Her a Fund-raiser, for Some Stupid Reason."
New York. By Eric Levitz. Here.
"Chelsea Clinton Is Holding a Fundraiser With the Embattled Theranos CEO."
Fortune. By Sy Mukherjee. Here.
"Theranos Founder Elizabeth Holmes to Host Clinton Fundraiser."
WSJ. By Peter Nicholas and John Carreyou. Here.
"Embattled Theranos CEO to Host Clinton Fundraiser."
March 16, 2016
"What Theranos Has to Lose by Hosting a Hillary Clinton Fundraiser."
StatNews. By David Nather. Here.
March 18, 2016
"Hillary Fundraiser Will Not Be Held at Theranos."
CNBC. By Eamon Javers. Here.
[Event will be held at private home of Susie Hwang and matt Glickman in Palo Alto. Holmes is listed 1st among the 11 female Silicon Valley hosts; "hosts" have contributed or raised >$2700.]
March 29, 2016
"Theranos Blood Testing Inconsistent with Other Labs, Study Shows."
BioPharmaDive. By Nicole Gray. Here.
Study by Kidd et al. in J Clin Invest, here. Theranos letter to editor, here (researchers did not contact us.) Reseachers did try to contact Theranos, per WSJ (here) and per The Verge (here). WaPo coverage, here. Forbes coverage, here.
March 31, 2016
"Theranos Devices Often Failed Accuracy Requirements."
Wall Street Journal. By John Carreyou. Here.
(WSJ reviews 121-page government report. "A redacted version was released...a full version was reviewed by WSJ.") Redacted version here.
Note: The Verge says "Theranos says it has performed nearly six million tests in the past two years." (here linking to Theranos here.) WSJ writes, "Government records show Theranos has performed 890,000 tests in the past year."
April 1, 2016
"Theranos Blood Tests Often Wildly Wrong, May be Shut Down by Feds"
Ars Technica. By Beth Mole. Here.
April 4, 2016
"Theranos Scandal Widens on Scathing Report."
Fox Business. By Steve Tobak. Here.
April 8, 2016
"Theranos Adds Startlingly Well Qualified Medical Board."
Fortune. By Roger Parloff. Here.
"Five of the six new members are either past presidents or past board members of the American Association for Clinical Chemistry." Press release here.
"Outside Experts Hired by Theranos See Promise But Still Seek Proof."Forbes. By Matthew Herper. Here.
"Unspinning the Theranos Scientific Advisory Board Communications Spin."
Telecareaware. By Donna Cusano. Here.
April 11, 2016
"Theranos Adds Medical Experts to Advisory Board."
Silicon Valley News. By Joseph Shieh. Here. [Includes bio's of 8 experts]
April 13, 2016
"Theranos Founder Elizabeth Holmes is Facing a Ban by Regulators."
Fortune. By Laura Lorenzetti. Here.
"Theranos Under Fire as U.S. Threatens Crippling Sanctions."
New York Times. By Reed Abelson & Andrew Pollack. Here.
"U.S. Government Wants to Ban Theranos' Elizabeth Holmes from Operating a Lab for Two Years."
The Verge. By Arielle Duhaine-Ross. Here.
Quote: "We are hopeful that CMS won’t impose sanctions," Theranos spokesperson Brooke Buchanan told The Verge in an emailed statement.
"Regulators Propose Banning Theranos Founder Elizabeth Holmes For At Least Two Years."
Wall Street Journal. By John Carreyou and Christopher Weaver. Here.
Several pages from CMS letter excerpted by the WSJ, here.
(Note: Within 5 hours, WSJ had posted 255 comments.)
(Full 44p letter not released due to company's request for redactions.)
Quote: "The appeals process could take months, and such appeals have rarely succeeded in the past. A list of appeals decisions on the agency’s website shows that the agency didn’t lose a single such case from 2001 to the end of 2010. [here]"
April 14, 2016
"Theranos Lab Threatened with CMS Ban, But Firm Says Corrections Have Been Made."
Gray Sheet. By Sue Darcey. Here.
"CMS Notifies Theranos of CLIA Sanctions That Include Revoking Clinical Laboratory’s CLIA License and a Two-Year Ban on Holmes, Balwani, and Dhawan."
Dark Daily. By Joseph Burns. Here.
"Things Aren't Going So Well for Theranos, Employer of Multiple Former TBWA [Advertising] Executives."
AgencySpy. By Patrick Coffee. Here.
Quote: "One of [the magazine features praising Holmes] was written by Laura Arrillaga-Andreessen, whose husband Marc happens to be a major venture capital investor in Theranos...NYT public editor Margaret Sullivan later agreed that this [NYT] article was ...an obvious conflict of interest." See October 29, 2015, above.
"What Theranos and Elizabeth Holmes Have Always Misunderstood."
Inc. By Jeff Bercovici. Here.
Inc. By Jeff Bercovici. Here.
Quote: "There's a reason almost no other health care startup's leadership looks like this. Pairing huge amounts of capital with minimal experience may be a great recipe for innovation in social media apps and on-demand services. But in health care, a little knowledge is a dangerous thing."
April 19, 2016
"Theranos Is Under Investigation for Fraud, Which Is Weird for a Private Company."Wired. By Nick Stockton. Here.
See his earlier article, October 29, 2015, "The Theranos Scandal Could Become a Legal Nightmare." Here.
"Theranos Director Defends CEO, Says Investors Have Faith."Bloomberg. By Sheelah Kolhatkar. Here.
April 20, 2016
"Theranos Is the Collision of Hope and Greed."
TIME. By Arthur L. Caplan. Here.
April 20, 2016
"Theranos Is the Collision of Hope and Greed."
TIME. By Arthur L. Caplan. Here.
April 21, 2016
"Can Theranos Survive Without Elizabeth Holmes?"
Fortune. [VIDEO discussion]. Here.
"A Marriage Gone Bad: Walgreens Struggles to Shake Off Theranos."
New York Times. By Randall B. Stoss. Here.
Fortune. [VIDEO discussion]. Here.
"A Marriage Gone Bad: Walgreens Struggles to Shake Off Theranos."
New York Times. By Randall B. Stoss. Here.
PAIR: April 21/April 22
[A] "How Elizabeth Holmes is Scoring PR Points for Theranos."
Fortune. By Mary Civiello. Here.
[B] "Is Theranos Really Winning the PR War?"
Adweek/PRNewser. By Shawn Paul Wood. Here.
Adweek/PRNewser. By Shawn Paul Wood. Here.
April 22, 2016
"The Rise and Fall of Theranos."
Scientific American. By Norman A. Paradis. Here.
Scientific American. By Norman A. Paradis. Here.
"Theranos has gotten only one test cleared by the FDA. That test—for Herpes infection—is for the detection of antibodies, not a measurement of their concentration. Tests for the presence or absence of a molecule are much simpler than those that quantify its concentration." Co-published at TheConversation, here.
April 23, 2016
"Blood Sports."
Economist. [No author]. Here.
Economist. [No author]. Here.
April 24, 2016
"Theranos' Fate Rests With a Founder Who Answers Only to Herself."
New York Times. By Reed Abelson. Here.
April 27, 2016
"Don't Blame Silicon Valley for Theranos."
New York Times. By Randall Stoss. Here.
"Theranos Lab Problems Go Way Deeper Than Its Secret Tech."
Wired. By Nick Stockton. Here.
"The Theranos Crisis: Where Was the Board?"Forbes. By Pamela Wasley. Here.
"The Theranos Crisis: Where Was the Board?"Forbes. By Pamela Wasley. Here.
April 28, 2016
"Theranos Woes Offer Lesson in How Labs Should Be Regulated."
Forbes. By Scott Gottleib. Here.
April 29, 2016
"Theranos Exposes Perverse Incentives in Silicon Valley."
Quartz. By Jay Edelson & Christore Dore. Here.
May 2, 2016
"The Secret Culprit in the Theranos Mess."
Vanity Fair. By Nick Bilton. Here. [Culprit = Silicon Valley tech media]
Vanity Fair. By Nick Bilton. Here. [Culprit = Silicon Valley tech media]
"Carreyrou told [Bilton] an entourage of lawyers arrived at the Journal’s Midtown Manhattan offices at one P.M. on June 23. The pack confidently sauntered past editors and reporters in the fifth-floor newsroom .... the lawyers placed two audio recorders at either end of the long oval wood table, and recalcitrantly sat across from Carreyrou, his editor, and a Journal lawyer. Then they hit record. Almost immediately, one person present told me, Boies and his team threatened legal action against the paper, accusing it of being in possession of “proprietary information..."
"Theranos Sent David Boies and a Team of Lawyers to the Wall Street Journal to Try and Stop Its Bombshell Story."
Business Insider. By Lydia Ramsay. Here. [Quoting Vanity Fair, Bilton, above]
"Biotech Theranos Offers a Cautionary Tale for Silicon Valley."
NPR. All Tech Considered. By Laura Sydell. Here.
NPR. All Tech Considered. By Laura Sydell. Here.
"Here's What Warren Buffett Thinks of Theranos and its Star Studded Board."
Finance.Yahoo.com By Daniel Roberts. Here.
Finance.Yahoo.com By Daniel Roberts. Here.
May 4, 2016
"Everything You Need to Know About the Theranos Saga So Far."
Wired. By Nicholas Stockton. Here.
Wired. By Nicholas Stockton. Here.
"FDA Looks to Clamp Down on Laboratory-Developed Tests and Put an End to ‘Wild West of Medicine’: Might CLIA Problems at Theranos Support FDA’s Position?"
Dark Daily. By Andrea Downing Peck. Here.
[Answer to the title question: Yes.]
May 5, 2016
"The Fall of Theranos and the Future of Silicon Valley."
TIME. By Lev Grossman. Here.
TIME. By Lev Grossman. Here.
May 9, 2016
"Bleeding Out: Theranos Oozes with Corporate Governance Lessons."
Compliance Week. By Jaclyn Jaeger. Here.
May 11, 2016
"Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes."
WSJ. By John Carreyou. Here.
May 13, 2016
"Theranos is Wrong: We Don't Need More Blood Tests."
538.com. By Katherine Hobson. Here.
May 18, 2016
"Theranos Voids Two Years of Edison Blood Test Results."
WSJ. By John Carreyou. Here.
May 19, 2016
"Theranos CEO Elizabeth Holmes Needs an Assist. Literally."
Fortune. By Dan Primack. Here.
[Advertisement for CEO executive assistant.]
May 25, 2016
"Craving Growth, Walgreens Dismissed Its Theranos Doubts."
WSJ. By Christopher Weaver and John Carreyou. Here.
May 27, 2016
"Theranos Lawsuits Start to Add Up."
CNN. By Sara Ashley O'Brien. [Class action effort filed with court.] Here.
"After the Theranos Mess, Can We Finally Quit Idolizing Entrepreneurs?"
Fortune. By Steve Tobak. Here.
June 1, 2016
"From $4.5 billion to nothing: Forbes revises estimate of net worth of Theranos founder Elizabeth Holmes."
Forbes. By Matthew Herper. Here.
June 3, 2016
"Theranos Says Only 1% of Results Affected; Some Doubt Tests."
Bloomberg. By Rebecca Spalding and Caroline Chen. Here.
June 9, 2016
"Jennifer Lawrence Signs On For Big Screen Theranos Adaptation."
June 13, 2016
"Theranos Got Ditched By Its Biggest Partner - Here's What It Has Left."
June 24, 2016
"World's Most Loyal VC Says Theranos Critics Are Just Haters."
Vanity Fair. By Maya Kosoff. Here.
July 6, 2016
"Congress Is Demanding Theranos Explain How It's Going to Fix Itself."
July 7, 2016
"Elizabeth Holmes Is Barred from Running Lab for 2 Years."
New York Times. By Andrew Pollack. Here.
Open access similarly at: NPR, here.
Link to July 7, 2016 CMS CLIA Letter - here (33 pp).
July 8, 2016
"Elizabeth Holmes Will Remain CEO, Theranos Says, But It May Stop All Lab Operations."
Forbes. Mathew Herper. Here.
"Theranos' Downfall Isn't Just Elizabeth Holmes' Fault."
Slate. By Shannon Palus. Here.
July 9, 2016
"The Theranos Implosion and Robert Schiller on Short Selling and Complete Markets."
Forbes. By Tim Worstall. Here.
"The 9 Fiascos That Have Pretty Much Doomed Theranos."Wired. By Nick Stockton. Here.
July 26, 2016
"Stealth Research and Theranos: Reflections and Update 1 Year Later."
JAMA. By John P.A. Ioannidis. Here.
(Re overuse of blood tests, see similarly Katherine Hobson, May 13, 2016, above).
August 1, 2016
"Theranos' Holmes on the Rise and Fall and Maybe Rise Again of a Medical Tech Darling."
CNN. By Jen Christensen. [Lab tour by Sanjay Gupta] Here.
August 1, 2016.
Holmes Speaks at AACC Conference.
Forbes, Matthew Herper, Live Blog (archive) here.
WSJ, John Carreyou, here.
CNBC, article and video story, here.
Wired, Nick Stockton, here.
Youtube Archive (90 minutes): AACC, Youtube, here.
August 1, 2016
"Theranos' Highly-Anticipated Defense of Its Tech Is Called a Bait-and-Switch."
Fortune. By Sy Mukherjee. Here.
"How Theranos Created and Destroyed Investors' Trust."
Fortune. By Kent Grayson. Here.
August 2, 2016
"The Founder of Theranos Tries to Change the Subject."
The New Yorker. By Sheelah Kolhatkar. Here.
"How Theranos' Reboot Could Backfire."
Washington Post. By Carolyn Y. Johnson. Here.
August 3, 2016
"Theranos CEO Quietly Steps Down from Presidential Entrepreneurship Program."
August 11, 2016
"The Theranos Lesson: It's Not Enough to Keep an Eye Out for Lies."
Crain's Chicago Business. By Faye Flam. Here.
August 30, 2016
"Theranos Halts New Zika Test After FDA Inspection."
WSJ. By John Carreyou and Christopher Weaver. Here.
September 6, 2016
"The Way Theranos Reportedly Reacted to the Suicide of Its Chief Scientist Is Unbelievably Cold."
Business Insider. By Avery Hartmans. Here.
September 7, 2016
"Exclusive: How Elizabeth Holmes' House of Cards Came Tumbling Down."
Vanity Fair. By Nick Bilton. Here.
"The EpiPen Debacle Coupled with Theranos and Turing: Is This Industry Broken?"
Forbes. By Bill Rader. Here.
September 8, 2016
"Here's Why You Shouldn't Let a 19 Year Old Dropout Run a Medical Company."
Thrillist/Health. By Christina Stiehl. Here.
September 12, 2016
"How Theranos Won Over Arizona Republicans."
Vanity Faire. By Maya Kosoff. Here.
"Lessons from Theranos: Marketing in the Age of Disrupters."
Advertising Age. By Sarah Larcker. Here.
September 16, 2016
"Arizona Fell Hard for Theranos' Bluff."
Tucson.com. By Tim Steller. Here.
October 6, 2016
"Theranos Retreats from Lab Tests."
WSJ. By John Carreyou and Christopher Weaver. Here.
WSJ. By John Carreyou and Christopher Weaver. Here.
"Theranos Inc. said it will shut down its blood-testing facilities and shrink its workforce by more than 40%.
The moves mark a dramatic retreat by the Palo Alto, Calif., company and founder Elizabeth Holmes from their core strategy of offering a long menu of low-price blood tests directly to consumers. Those ambitions already were endangered by crippling regulatory sanctions that followed revelations by The Wall Street Journal of shortcomings in Theranos’s technology and operations.
The shutdowns and layoffs could help the closely held company accelerate its shift to developing products that could be sold to outside laboratories. Ms. Holmes announced in August a new blood-testing device called miniLab, which is about the size of a printer but hasn’t been approved by regulators...."
October 10, 2016
"Major Investor Sues Theranos."WSJ. By John Carreyou. Here.
Partner Fund Management, SF, had invested $100M.
October 11, 2016
"Downfall of a Unicorn: How Theranos Fell Apart."
BioPharmaDive. By Ned Pagliarulo. Here.
"Theranos Investor: We Want Our $96 Million Back."
CNN.com By Sara Ashley O'Brien. Here.
October 14, 2016
"Unsealed Investor Suit Alleges Specific Lies by Theranos."
Fortune. By Roger Parloff. Here.
"Theranos Legal Problems Keep Getting Worse."
Vanity Fair. By Emily Jane Fox. Here.
October 17, 2016
"Blood Diagnostics Startup Theranos Slammed with Cluster of Lawsuits."
Carrier Management [insurance] By Jef Feeley and Caroline Chen. Here.
October 18, 2016
"Theranos and the Dark Side of Storytelling."
Harvard Business Review. By Jonathan Gottschall. Here.
October 20, 2016
"Agony, Alarm, and Anger for People Hurt by Theranos' Botched Blood Tests."
WSJ. By Christopher Weaver. Here.
 |
| WSJ/Weaver/10/20/2016 |
November 8, 2016
"Walgreens sues Theranos for breach of contract, seeks $140M."
November 15, 2016
"Walgreens Trashes Theranos in Their Fiery $140M Lawsuit Battle."
Fortune. By Sy Mukherjee. Here.
Redacted Walgreens Complaint (52pp), here.
November 18, 2016
"Why is Elizabeth Holmes Still Leading Theranos?"
BizJournals. By Ron Leuty. Here.
"Theranos Whistleblower Shook the Company - and His Family."
November 20, 2016
"Famed Attorney David Boies Severs Legal Ties with Theranos."
WSJ. By John Carreyou. Here.
November 22, 2016
"Why Quest is Chasing the Consumer Testing Market."
Medcitynews. By Juliet Preston. Here.
November 28, 2016
"Big Names Take a Hit on Theranos."
WSJ. By Christopher Weaver, John Carreyou. Here.
"Newspaper That Brought Down Theranos Learns Owner Is Major Investor."
Gizmodo. By Eve Peyser. Here.
December 5, 2016
"Theranos Foresaw Huge Growth in Revenue and Profits."
WSJ. By Christopher Weaver and John Carreyou. Here.
December 6, 2016
"Theranos Forgets to Use BCC, Accidentally Outs Confidential Investors."
Vanity Fair. By Maya Kosoff. Here.
"Theranos Can't Even Send a G--- Email Right."
Gizmodo. By Hudson Hongo. Here.
December 7, 2016
"Trump's Mad Dog Stays as Theranos Cuts Figureheads and Outs Investors."
Ars Technica. By Beth Mole. Here.
Stepping down: Kissinger, Shultz, Perry, Bechtel, Sens. Nunn & Frist. Staying: Genl. James Mattis, nominated to Secretary of Defense.
___
After December 7, 2016, I stopped updating this blog.
For an update on the March 2018 SEC action against Theranos, here.
.
______
_____________________
To discuss how the changing healthcare system and Medicare policy affects your company, association, or investments, contact Dr Quinn through Bruce Quinn Associates LLC.
